Iovance Biotherapeutics Inc. Common Stock vs Ondas Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while Ondas Inc. Common Stock trades at $6.97 (market cap $4.19B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| IOVA | ONDS | |
|---|---|---|
Market Cap | $5.85B | $4.19B |
Volume | 14,517,176 | 61,559,166 |
Sector | Health | Technology |
52-Week High | $14.82 | $14.01 |
52-Week Low | $1.81 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $2.82B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →